APA (7th ed.) Citation

H, J., X, L., W, W., Y, H., & D, R. (2022). MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway. Oncology reports, 48(5), . https://doi.org/10.3892/or.2022.8418

Chicago Style (17th ed.) Citation

H, Jiang, Li X, Wang W, Hu Y, and Ren D. "MYCL Promotes the Progression of Triple‑negative Breast Cancer by Activating the JAK/STAT3 Pathway." Oncology Reports 48, no. 5 (2022). https://doi.org/10.3892/or.2022.8418.

MLA (9th ed.) Citation

H, Jiang, et al. "MYCL Promotes the Progression of Triple‑negative Breast Cancer by Activating the JAK/STAT3 Pathway." Oncology Reports, vol. 48, no. 5, 2022, https://doi.org/10.3892/or.2022.8418.

Warning: These citations may not always be 100% accurate.